Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
GEMP

Gemphire Therapeutics

$1.17

0.03 (2.63%)

08:04
12/03/18
12/03
08:04
12/03/18
08:04
Hot Stocks
Gemphire Therapeutics announces review of strategic alternatives »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

Over a month ago
GEMP

Gemphire Therapeutics

$1.40

0.005 (0.36%)

16:08
11/08/18
11/08
16:08
11/08/18
16:08
Earnings
Gemphire Therapeutics reports Q3 EPS (43c), consensus (47c) »

At September 30, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$12.03

0.63 (5.53%)

, ALBO

Albireo Pharma

$28.43

0.47 (1.68%)

08:17
10/17/18
10/17
08:17
10/17/18
08:17
Conference/Events
Roth Capital to hold a conference »

Roth Battle of the NASH…

GLMD

Galmed

$12.03

0.63 (5.53%)

ALBO

Albireo Pharma

$28.43

0.47 (1.68%)

CBAY

CymaBay

$11.06

0.93 (9.18%)

CNAT

Conatus

$5.22

0.34 (6.97%)

ENTA

Enanta

$80.30

4.11 (5.39%)

GALT

Galectin Therapeutics

$5.14

0.25 (5.11%)

GEMP

Gemphire Therapeutics

$1.71

0.08 (4.91%)

ICPT

Intercept

$107.66

6.11 (6.02%)

MDGL

Madrigal Pharmaceuticals

$204.86

15.12 (7.97%)

ZFGN

Zafgen

$10.46

0.47 (4.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 22

    Oct

  • 20

    Nov

GEMP

Gemphire Therapeutics

$2.32

-0.035 (-1.49%)

17:08
09/24/18
09/24
17:08
09/24/18
17:08
Hot Stocks
Gemphire Therapeutics to cut 33% of staff and take a $1.4M related charge »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ARCT

Arcturus Therapeutics

$8.08

0.12 (1.51%)

, ICAD

iCAD

$2.92

0.05 (1.74%)

07:07
08/28/18
08/28
07:07
08/28/18
07:07
Hot Stocks
Arcturus Therapeutics appoints Andrew Sassine interim CFO »

Arcturus Therapeutics…

ARCT

Arcturus Therapeutics

$8.08

0.12 (1.51%)

ICAD

iCAD

$2.92

0.05 (1.74%)

GEMP

Gemphire Therapeutics

$1.39

-0.05 (-3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

GEMP

Gemphire Therapeutics

$1.55

-0.1 (-6.06%)

16:35
08/20/18
08/20
16:35
08/20/18
16:35
Hot Stocks
Breaking Hot Stocks news story on Gemphire Therapeutics »

Venrock Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$1.64

-0.15 (-8.38%)

16:06
08/13/18
08/13
16:06
08/13/18
16:06
Hot Stocks
Gemphire Therapeutics sees sufficient resources to fund operations through 4Q19 »

Based on current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$1.65

-0.14 (-7.82%)

16:04
08/13/18
08/13
16:04
08/13/18
16:04
Earnings
Gemphire Therapeutics reports Q2 EPS (47c), consensus (55c) »

At June 30, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$1.79

-1.47 (-45.09%)

09:06
08/13/18
08/13
09:06
08/13/18
09:06
Downgrade
Gemphire Therapeutics rating change at Jefferies »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEMP

Gemphire Therapeutics

$3.26

(0.00%)

09:43
08/10/18
08/10
09:43
08/10/18
09:43
Downgrade
Gemphire Therapeutics rating change  »

Gemphire Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.